Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Righttothetopon Jan 14, 2021 12:12pm
303 Views
Post# 32297273

RE:RE:RE:RE:Awesome

RE:RE:RE:RE:AwesomeI think most rational people who know and follow this stock realized that it had potential even beyond the recent miscues.

Hopefully they can provide hard proof that they turned the ship around cause at these levels, LABS is a steal if they did....

A nice CEO announcement would do wonders as well.  Positive directions probably make it much easier to attract some high prized talent certainly.....a complete rebuild is a different animal to sell compared to fine tuning.

So far 2021 is showing that LABS has some life left in her; depending on what the international update says, taking anything off the table pre-Q4 may not be a good idea....but we shall see.....

Lemoyne wrote: I think private brand sales are really encouraging, with sqdc eventually piling on, this has significant potential to continue growing over the whole of 2021 (retail + new provinces ramping up).

internationally, i'm optimistic this will also increase in Q4 but most importantly, the announcement of stada shipment could number in 10's of thousands of units, maybe reaching 100k + IF they manage to ship in february = serious catalyst.

Rockstar CxOs could also help consolidate positive sentiment.

That will not change the fact I will swing my stock if I feel it's overpriced come Q4 earnings. We all know what Labs is capable of when earnings are announced.


<< Previous
Bullboard Posts
Next >>